These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 26361042

  • 1. PD-1 Blockade Can Restore Functions of T-Cells in Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma In Vitro.
    Quan L, Chen X, Liu A, Zhang Y, Guo X, Yan S, Liu Y.
    PLoS One; 2015; 10(9):e0136476. PubMed ID: 26361042
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus (EBV) positive diffuse large B cell lymphoma of the elderly-experience of a single center from Turkey.
    Ozsan N, Cagirgan S, Saydam G, Gunes A, Hekimgil M.
    Pathol Res Pract; 2013 Aug; 209(8):471-8. PubMed ID: 23726928
    [Abstract] [Full Text] [Related]

  • 3. Increased T-cell responses to Epstein-Barr virus with high viral load in patients with Epstein-Barr virus-positive diffuse large B-cell lymphoma.
    Morishima S, Nakamura S, Yamamoto K, Miyauchi H, Kagami Y, Kinoshita T, Onoda H, Yatabe Y, Ito M, Miyamura K, Nagai H, Moritani S, Sugiura I, Tsushita K, Mihara H, Ohbayashi K, Iba S, Emi N, Okamoto M, Iwata S, Kimura H, Kuzushima K, Morishima Y.
    Leuk Lymphoma; 2015 Apr; 56(4):1072-8. PubMed ID: 24975317
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus (EBV) provides survival factors to EBV+ diffuse large B-cell lymphoma (DLBCL) lines and modulates cytokine induced specific chemotaxis in EBV+  DLBCL.
    Wu L, Ehlin-Henriksson B, Zhou X, Zhu H, Ernberg I, Kis LL, Klein G.
    Immunology; 2017 Dec; 152(4):562-573. PubMed ID: 28699226
    [Abstract] [Full Text] [Related]

  • 5. Epstein-Barr virus presence in pediatric diffuse large B-cell lymphoma reveals a particular association and latency patterns: analysis of viral role in tumor microenvironment.
    Cohen M, De Matteo E, Narbaitz M, Carreño FA, Preciado MV, Chabay PA.
    Int J Cancer; 2013 Apr 01; 132(7):1572-80. PubMed ID: 22987474
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus-positive diffuse large B-cell lymphoma association is not only restricted to elderly patients.
    Cohen M, Narbaitz M, Metrebian F, De Matteo E, Preciado MV, Chabay PA.
    Int J Cancer; 2014 Dec 15; 135(12):2816-24. PubMed ID: 24789501
    [Abstract] [Full Text] [Related]

  • 7. Expression of co-inhibitory molecules B7-H4 and B7-H1 in Epstein-Barr virus positive diffuse large B-cell lymphoma and their roles in tumor invasion.
    Jiang Y, Lin J, Zhang J, Lu S, Wang C, Tong Y.
    Pathol Res Pract; 2019 Dec 15; 215(12):152684. PubMed ID: 31679792
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus-positive diffuse large B-cell lymphomas of the elderly.
    Adam P, Bonzheim I, Fend F, Quintanilla-Martínez L.
    Adv Anat Pathol; 2011 Sep 15; 18(5):349-55. PubMed ID: 21841405
    [Abstract] [Full Text] [Related]

  • 9. Epstein-Barr virus-negative diffuse large B-cell lymphoma hosts intra- and peritumoral B-cells with activated Epstein-Barr virus.
    Stuhlmann-Laeisz C, Szczepanowski M, Borchert A, Brüggemann M, Klapper W.
    Virchows Arch; 2015 Jan 15; 466(1):85-92. PubMed ID: 25339301
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus-positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus-positive diffuse large B-cell lymphoma of the elderly.
    Uccini S, Al-Jadiry MF, Scarpino S, Ferraro D, Alsaadawi AR, Al-Darraji AF, Moleti ML, Testi AM, Al-Hadad SA, Ruco L.
    Hum Pathol; 2015 May 15; 46(5):716-24. PubMed ID: 25704629
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr Virus Infection of Cell Lines Derived from Diffuse Large B-Cell Lymphomas Alters MicroRNA Loading of the Ago2 Complex.
    Ayoubian H, Ludwig N, Fehlmann T, Menegatti J, Gröger L, Anastasiadou E, Trivedi P, Keller A, Meese E, Grässer FA.
    J Virol; 2019 Feb 01; 93(3):. PubMed ID: 30429351
    [Abstract] [Full Text] [Related]

  • 12. The perivascular microenvironment in Epstein-Barr virus positive primary central nervous system lymphoma: The role of programmed cell death 1 and programmed cell death ligand 1.
    Sugita Y, Furuta T, Ohshima K, Komaki S, Miyoshi J, Morioka M, Abe H, Nozawa T, Fujii Y, Takahashi H, Kakita A.
    Neuropathology; 2018 Apr 01; 38(2):125-134. PubMed ID: 29067721
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas.
    Anastasiadou E, Stroopinsky D, Alimperti S, Jiao AL, Pyzer AR, Cippitelli C, Pepe G, Severa M, Rosenblatt J, Etna MP, Rieger S, Kempkes B, Coccia EM, Sui SJH, Chen CS, Uccini S, Avigan D, Faggioni A, Trivedi P, Slack FJ.
    Leukemia; 2019 Jan 01; 33(1):132-147. PubMed ID: 29946193
    [Abstract] [Full Text] [Related]

  • 14. Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study.
    Hu LY, Xu XL, Rao HL, Chen J, Lai RC, Huang HQ, Jiang WQ, Lin TY, Xia ZJ, Cai QQ.
    Chin J Cancer; 2017 Dec 16; 36(1):94. PubMed ID: 29246182
    [Abstract] [Full Text] [Related]

  • 15. The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma.
    Keane C, Tobin J, Gunawardana J, Francis S, Gifford G, Gabrielli S, Gill A, Stevenson W, Talaulikar D, Gould C, Jain S, Birch S, Hertzberg M, Gandhi MK.
    Eur J Haematol; 2019 Sep 16; 103(3):200-207. PubMed ID: 31211907
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus is rarely associated with diffuse large B cell lymphoma in Taiwan and carries a trend for a shorter median survival time.
    Chang ST, Lu YH, Lu CL, Weng SF, Lin SH, Kuo SY, Chuang YT, Takeuchi K, Ohshima K, Chuang SS.
    J Clin Pathol; 2014 Apr 16; 67(4):326-32. PubMed ID: 24218026
    [Abstract] [Full Text] [Related]

  • 17. Clinicopathological analysis of primary intestinal diffuse large B-cell lymphoma: Prognostic evaluation of CD5, PD-L1, and Epstein-Barr virus on tumor cells.
    Ishikawa E, Kato S, Shimada K, Tanaka T, Suzuki Y, Satou A, Kohno K, Sakakibara A, Yamamura T, Nakamura M, Miyahara R, Goto H, Nakamura S, Hirooka Y.
    Cancer Med; 2018 Dec 16; 7(12):6051-6063. PubMed ID: 30449068
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. MiR155 sensitized B-lymphoma cells to anti-PD-L1 antibody via PD-1/PD-L1-mediated lymphoma cell interaction with CD8+T cells.
    Zheng Z, Sun R, Zhao HJ, Fu D, Zhong HJ, Weng XQ, Qu B, Zhao Y, Wang L, Zhao WL.
    Mol Cancer; 2019 Mar 30; 18(1):54. PubMed ID: 30925928
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.